Alamar Biosciences, Inc.: 10% owner Qiming Corporate sold 173,673 shares

What happened

• Qiming Corporate GP VI, Ltd., listed as a 10% owner, reported multiple open-market sales of common stock on Oct 15 and Oct 16, 2026. The filing lists sales totaling 173,673 shares at reported prices of $27.73, $28.26 and $27.02, with total proceeds of $4,816,122.
• The filing's footnote F1 says some reported prices are weighted averages and that those sales occurred at prices ranging from $27.26 to $28.23; the filer offers to provide details on the number of shares sold at each separate price on request.

Key details

• Transaction dates and prices: Oct 15, 2026 and Oct 16, 2026; reported prices include $27.73, $28.26 and $27.02 (weighted-average range for some sales: $27.26 to $28.23).
• Shares sold: 173,673 shares; total reported proceeds: $4,816,122.
• Shares owned after the transaction: not specified in the provided filing excerpt.
• Relevant footnotes: F2–F5 note that many shares are held of record by various Qiming funds (Qiming Managing Directors Fund VI, Qiming Venture Partners VI, QVP VIII LLC, QVP VIII-HC) and that Qiming Corporate may be deemed to have voting and dispositive power over those shares while disclaiming beneficial ownership except to the extent of its pecuniary interest.
• Filing timing: reported on Form 4 filed Oct 19, 2026 for transactions on Oct 15 and Oct 16, 2026; the filing does not indicate a late filing.

Why it may matter

• These were open-market sales, not option exercises, gifts, or awards as described in the filing.
• The reporting entity is a 10% owner (a large holder), not identified as an executive in the filing.
• A filing does not show why the insider traded or why the company acted.